妊娠期血小板减少的病因及结局

Abstract
Figure/Table
References
Related Citation (6)

Download: PDF (591 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the etiology and outcome of gestational thrombocytopenia. Methods The clinical data on 146 cases of gestational thrombocytopenia treated in Beijing Shijitan Hospital between January 2010 and December 2016 was retrospectively analyzed. These patients were divided into three groups: group Ⅰin which the platelet count was above 50×10⁹/L, group Ⅱ in which the platelet count was between (30-50)×10⁹/L, and group Ⅲ whose platelet count was lower than 30×10⁹/L. The cause of disease was explored in order to offer targeted treatment. The platelet count of group Ⅰ was monitored closely. Patients vulnerable to bleeding in groups Ⅱ and Ⅲ were treated with glucocorticoid and had their platelet count dynamically monitored. Importance was attached to perinatal surveillance and postpartum visits so as to find out more about the cause of disease. Results The main causes of gestational thrombocytopenia included pregnancy associated thrombocytopenia (PAT), idiopathic thrombocytopenic purpura (ITP) and pregnancy complications. Gestational thrombocytopenia was one of the most important signs of autoimmune diseases. Patients with platelet counts <30×10⁹/L had a significantly higher rate of cesarean section and platelet transfusion than those with platelet counts of (30-50)×10⁹/L and (50-100)×10⁹/L (P<0.05). Conclusions Clear diagnoses are required in case of gestational thrombocytopenia. Different treatment methods and different ways of delivery should be applied according to etiologies, severity of thrombocytopenia and degree of urgency. Follow-up should last for 3 years after delivery.

Received: 20 June 2018

ZTFLH:

R714.2

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WANG Huiying
	YE Yixuan
	YU Shasha
	and ZHAO Miansong

Cite this article:

WANG Huiying,YE Yixuan,YU Shasha等. Etiology and outcomes of gestational thrombocytopenia[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2019, 30(1): 51-53.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2019/V30/I1/51

[1]	Veneri D, Franchini M, Randon F, et al.Thrombocytopenias : a clinical point of view [J]. Blood Transfus, 2009, 7(2): 75-85.
[2]	Nishikawa A,Mmimura K,Kanagawa T,et al.Thrombocytopenia associated with＼r Mycoplasma＼r pneumonia during pregnancy: case presentation and approach for differential diagnosis [J].J Obstet Gynaecol Res,2015,4l(8):1273-1277.
[3]	McCrae K R. Thrombocytopenia in pregnancy [J]. Blood Rev, 2003, 17(1): 7-14.
[4]	Schwartz K A. Gestational thrombocytopenia and immune thrombocytopenia in pregnancy [J]. Hematol Clin North Am, 2000, 14(5): 1101-1109.
[5]	Parnas M, Sheiner E. Moderate to severe thrombocytopenia during pregnancy [J]. Eur J Obstet Gynecol Reprod Biol, 2006, 10(3): 146-164.
[6]	Kam P C, Thompson S A, Liew A C. Review article, thrombocytopenia in the parturient[J]. Anaesthesia, 2004, 59: 255-264.
[7]	刘杨. 113例妊娠合并血小板减少临床分析[J]. 中外妇儿健康, 2011, 19(8): 59.
[8]	施建飞, 汤春辉. 妊娠合并血小板减少108例临床分析[J]. 中国实用妇科与产科杂志, 2006, 22(12): 930.
[9]	徐雪,梁梅英,郭天元.2014年日本“妊娠合并特发性血小板减少性紫癜诊治共识”解读[J].中华围产医学杂志,2015,18(4):246-251.
[10]	华凯, 周春华. 妊娠合并特发性血小板减少性紫癜处理进展 [J].国外医学妇产科分册, 2000, 27(1): 29-31.
[11]	Palta A,Dhiman P.Thrombocytopenia in pregnaney[J].J Obstet Gynaecol,2016,36(2):146-52.